District Court, D. New Jersey June 23, 1998, Civ. 98-2006(WGB), 98-2143 (JAG) (Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.)

OPINION

BASSLER, District Judge.

Plaintiff Ben Venue Laboratories, Inc., a generic drug manufacturer, moves for a preliminary injunction requiring Defendant Novartis Pharmaceuticals Corp., a brand name drug manufacturer, to remove its patent from the Food and Drug Administration’s “Orange Book.” Plaintiff subsequently filed a motion for leave to file a supplemental complaint.